Comparison of testing methods assessing the in vitro efficacy of the combination of aztreonam with avibactam on multidrug-resistant Gram-negative bacilli

被引:1
作者
Deckers, Corentin [1 ,2 ]
Belik, Florian [1 ,2 ]
Denis, Olivier [1 ,2 ]
Bogaerts, Pierre [1 ,2 ]
Montesinos, Isabel [1 ,2 ]
Berhin, Catherine [1 ,2 ]
Bouchahrouf, Warda [1 ,2 ]
Hoebeke, Martin [1 ,2 ]
Evrard, Stephanie [1 ,2 ]
Gilliard, Nicolas [1 ,2 ]
Okur, Merve [1 ,2 ]
Huang, Te-Din [1 ,2 ]
机构
[1] CHU UCL Namur, Natl Reference Ctr Antibiot Resistant Gram Negat B, Ave Gaston Therasse 1, B-5530 Yvoir, Belgium
[2] Catholic Univ Louvain, Ave Gaston Therasse 1, B-5530 Yvoir, Belgium
关键词
Antibiotic combination; Carbapenemase; Metallo-beta-lactamase; Antibiotic susceptibility testing; Aztreonam-avibactam;
D O I
10.1186/s12941-024-00708-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Aztreonam-avibactam (ATM-AVI) combination shows promising effectiveness on most carbapenemase-producing Gram-negatives, yet standardized antibiotic susceptibility testing (AST) methods for evaluating the combination in clinical laboratories is lacking. We aimed to evaluate different ATM-AVI AST approaches.Methods 96 characterized carbapenem-resistant clinical isolates belonging to 9 Enterobacterales (EB; n = 80) and P. aeruginosa (PA; n = 16) species, including 90 carbapenemase producers and 72 strains resistant to both CAZ-AVI and ATM, were tested. Paper disk elution (DE; Bio-Rad) and E-test gradient strips stacking (SS; bioM & eacute;rieux) were performed for the ATM + CAZ-AVI combination. MIC Test Strip (MTS; Liofilchem) was evaluated for ATM-AVI MIC determination. Results were interpreted applying ATM clinical breakpoints of the EUCAST guidelines and compared to the broth microdilution method (Sensititre, Thermofisher).Results According to broth microdilution method, 93% of EB and 69% of PA were tested susceptible to ATM-AVI. The synergistic effect of ATM-AVI was of 95% for EB, but of only 17% for PA. The MTS method yielded higher categorical and essential agreement (CA/EA) rates for both EB (89%/91%) and PA (94%/94%) compared to SS, where the rates were 87%/83% for EB and 81%/81% for PA. MTS and SS yielded 2 and 3 major discrepancies, respectively, while 3 very major discrepancies each were observed for both methods. Concerning the DE method, CA reached 91% for EB and 81% for PA, but high number of very major discrepancies were observed for EB (n = 6; 8%) and for PA (n = 3; 19%).Conclusions The ATM-AVI association displayed excellent in vitro activity against highly resistant clinical Enterobacterales strains. MTS method offers accurate ATM-AVI AST results, while the SS method might serve as better alternative then DE method in assessing the efficacy of ATM + CAZ-AVI combination. However, further investigation is needed to confirm the methods' ability to detect ATM-AVI resistance.
引用
收藏
页数:9
相关论文
共 25 条
[1]   In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review [J].
Aslan, Abdullah Tarik ;
Ezure, Yukiko ;
Horcajada, Juan Pablo ;
Harris, Patrick N. A. ;
Paterson, David L. .
FRONTIERS IN MEDICINE, 2023, 10
[2]   Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020 [J].
Bhatnagar, Amelia ;
Boyd, Sandra ;
Sabour, Sarah ;
Bodnar, Janine ;
Nazarian, Elizabeth ;
Peinovich, Nadine ;
Wagner, Christine ;
Craft, Bradley ;
Vagnone, Paula Snippes ;
Simpson, Justin ;
Stone, Victoria N. ;
Therrien, Michelle ;
Bateman, Allen ;
Lower, Danielle ;
Huang, Jennifer Y. ;
Gumbis, Stephanie ;
Lonsway, David ;
Lutgring, Joseph D. ;
Karlsson, Maria ;
Brown, Allison C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
[3]   Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing Enterobacteriaceae [J].
Biagi, M. ;
Wu, T. ;
Lee, M. ;
Patel, S. ;
Butler, D. ;
Wenzler, E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (12)
[4]  
ClinicalTrials.gov, Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
[5]  
ClinicalTrials.gov, STUD DET EFF SAF TOL
[6]   Comparison of ETEST® superposition method and the MTS™ Aztreonam-avibactam strip with the reference method for aztreonam/avibactam susceptibility testing [J].
Deschamps, Manon ;
Dauwalder, Ollivier ;
Dortet, Laurent .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (03) :685-687
[7]  
Emeraud C, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00010-19, 10.1128/aac.00010-19]
[8]   Evaluation of the MTS™ aztreonam-avibactam strip (Liofilchem) on New Delhi metallo-β-lactamase-producing Enterobacterales [J].
Emilie, Cardot Martin ;
Alice, Colombier Marie ;
Marine, Gougeon ;
Farfour, Eric ;
Pourbaix, Annabelle ;
Dortet, Laurent ;
Lucie, Limousin ;
Marc, Vasse .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (04) :777-784
[9]   Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales [J].
Falcone, Marco ;
Daikos, George L. ;
Tiseo, Giusy ;
Bassoulis, Dimitrios ;
Giordano, Cesira ;
Galfo, Valentina ;
Leonildi, Alessandro ;
Tagliaferri, Enrico ;
Barnini, Simona ;
Sani, Spartaco ;
Farcomeni, Alessio ;
Ghiadoni, Lorenzo ;
Menichetti, Francesco .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) :1871-1878
[10]  
Huang T-D., 2023, Microbiological surveillance of carbapenemase-producing Enterobacterales (CPE) in Belgium